Is metabolic syndrome related with coronary artery disease severity and complexity: An observational study about IDF and AHA/NHLBI metabolic syndrome definitions

Cardiology Journal

Volumn 21, Issue 3, 2014, Pages 245-251

  Aykan, Ahmet Çaǧi ^a   Gül, Ilker ^a   Kalaycioǧlu, Ezgi ^a   Gökdeniz, Tayyar ^a   Hatem, Engin ^a   Menteşe, Ümit ^a   Yildiz, Banu Şahin ^b   Yildiz, Mustafa ^c  

^a Ahi Evren Chests and Cardiovascular Surgery Training and Research Hospital   (Turkey)

^b Kartal Lutfi Kirdar Education and Research Hospital   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

AHA NHLBI; Cardiovascular; Coronary; IDF; Metabolic syndrome; Syntax score

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HEALTH CARE ORGANIZATION; HEART LEFT VENTRICLE MASS; HIP CIRCUMFERENCE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERNATIONAL DIABETES FEDERATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MERCURY SPHYGMOMANOMETER; METABOLIC SYNDROME X; NATIONAL HEART LUNG BLOOD INSTITUTE; OBSERVATIONAL STUDY; PREVALENCE; PROSPECTIVE STUDY; SYNTAX SCORE; TRANSTHORACIC ECHOCARDIOGRAPHY; WAIST CIRCUMFERENCE; CLASSIFICATION; COMPLICATION; FOLLOW UP; METABOLISM; MIDDLE AGED; PROGNOSIS; RISK FACTOR; TURKEY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SOCIETIES, MEDICAL; TURKEY;

EID: 84902212275     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/CJ.a2013.0126     Document Type: Article

References (26)

1. Grundy SM, Cleeman JI, Daniels SR et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation, 2005; 112: 2735-2752.
2. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: A new worldwide definition. Lancet, 2005; 366: 1059-1062.
3. Gami AS, Witt BJ, Howard DE et al. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol, 2007; 49: 403-414.
4. Mottillo S, Filion KB, Genest J et al. The metabolic syndrome and cardiovascular risk. A systematic review and meta-analysis. J Am Coll Cardiol, 2010; 56: 1113-1132.
5. Ertek S, Cicero A F, Cesur M et al. The severity of coronary atherosclerosis in diabetic and non-diabetic metabolic syndrome patients diagnosed according to different criteria and undergoing elective angiography. Acta Diabetol, 2011; 48: 21-27.
6. Bayturan O, Tuzcu EM, Uno K et al. Comparison of rates of progression of coronary atherosclerosis in patients with diabetes mellitus versus those with the metabolic syndrome. Am J Cardiol, 2010; 105: 1735-1739.
7. Zornitzki T, Ayzenberg O, Gandelman G et al. Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women. QJM, 2007; 100: 575-581.
8. Anderson J, Horne B, Jones H et al. Which features of metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease? Cardiology, 2004; 101: 185-193.
9. Timóteo AT, Mota Carmo M, Cruz Ferreira R. Does metabolic syndrome predict significant angiographic coronary artery disease? Rev Port Cardiol, 2012; 31: 769-778.
10. Yoon SE, Ahn SG, Kim JY et al. Differential relationship between metabolic syndrome score and severity of coronary atherosclerosis as assessed by angiography in a non-diabetic and diabetic Korean population. J Korean Med Sci, 2011; 26: 900-905.
11. Sianos G, Morel MA, Kappetein AP et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention, 2005; 1: 219-227.
12. Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C, Tamburino C. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv, 2009; 2: 302-308.
13. Aykan AC, Gül I, Gökdeniz T et al. Is coronary artery disease complexity valuable in the prediction of contrast induced nephropathy besides Mehran Risk Score, in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention? Heart Lung Circ, 2013; 22: 836-843.
14. Gökdeniz T, Boyaci F, Hatem E et al. SYNTAX score predicts the left ventricle thrombus development in patients undergoing primary percutaneous coronary intervention for first anterior myocardial infarction. Clin Appl Thromb Hemost, Epub. 2013 Feb 22.
15. Marso S P, Mercado N, Maehara A et al. Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes. J Am Coll Cardiol Cardiovasc Imaging, 2012; 5 (3 suppl.): 42-52.
16. Zheng M, Choi SY, Tahk SJ et al. The relationship between volumetric plaque components and classical cardiovascular risk factors and the metabolic syndrome a 3-vessel coronary artery virtual histology-intravascular ultrasound analysis. J Am Coll Cardiol Cardiovasc Interv, 2011; 4: 503-510.
17. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment oh High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, valuation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) fnal report. Circulation, 2002; 106: 3143-3421.
18. Alberti KG, Eckel RH, Grundy SM et al.; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 2009; 120: 1640-1645.
19. Malik S, Wong ND, Franklin SS et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004; 110: 1245-1250.
20. Al-Aqeedi R F, Abdullatef WK, Dabdoob W, Bener A, Albinali HA, Gehani A. The prevalence of metabolic syndrome components, individually and in combination, in male patients admitted with acute coronary syndrome, without previous diagnosis of diabetes mellitus Libyan J Med, 2013; 8: 20185.
21. Lawlor DA, Dawey Smith G, Ebrahim S. Does the new International Diabetes Federation definition of metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's heart and health study. Diabetologia, 2006; 49: 41-48.
22. Tsai S P, Wen C P, Chan H T, Chiang PH, Tsai MK, Cheng TY. The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality. Diabetes Res Clin Pract, 2008; 82: 148-156.
23. Protopsaltis I, Nikolopoulos G, Dimou E et al. Metabolic syndrome and its components as predictors of all-cause mortality and coronary heart disease in type 2 diabetic patients. Atherosclerosis, 2007; 195: 189-194.
24. Tong PC, Kong A P, So WY et al. The usefulness of International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care, 2007; 30: 1206-1211.
25. Laclaustra M, Ordonez B, Leon M et al. Metabolic syndrome and coronary heart disease among Spanish male workers: A case-control study of MESYAS. Nutr Metab Cardiovasc Dis, 2012; 22: 510-516.
26. Kato M, Dote K, Naganuma T et al. Clinical predictors of culprit plaque rupture assessed on intravascular ultrasound in acute coronary syndromes. Circ J, 2010; 74: 1936-1942.